Chemoinformaics analysis of ISOVALERIC-ACID-N-OCTYL-ESTER
| Molecular Weight | 618.855 | nRot | 4 |
| Heavy Atom Molecular Weight | 564.423 | nRig | 35 |
| Exact Molecular Weight | 618.392 | nRing | 6 |
| Solubility: LogS | -4.087 | nHRing | 0 |
| Solubility: LogP | 6.843 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 99 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 54 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 39 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 105.949 |
| nHD | 3 | BPOL | 57.6452 |
| QED | 0.179 |
| Synth | 5.067 |
| Natural Product Likeliness | 2.832 |
| NR-PPAR-gamma | 0.969 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.034 |
| Pgp-sub | 0.003 |
| HIA | 0.028 |
| CACO-2 | -5.348 |
| MDCK | 0.0000164 |
| BBB | 0.198 |
| PPB | 1.00202 |
| VDSS | 0.699 |
| FU | 0.0168487 |
| CYP1A2-inh | 0.009 |
| CYP1A2-sub | 0.379 |
| CYP2c19-inh | 0.044 |
| CYP2c19-sub | 0.85 |
| CYP2c9-inh | 0.105 |
| CYP2c9-sub | 0.959 |
| CYP2d6-inh | 0.025 |
| CYP2d6-sub | 0.24 |
| CYP3a4-inh | 0.16 |
| CYP3a4-sub | 0.478 |
| CL | 3.585 |
| T12 | 0.022 |
| hERG | 0.008 |
| Ames | 0.01 |
| ROA | 0.192 |
| SkinSen | 0.026 |
| Carcinogencity | 0.038 |
| EI | 0.015 |
| Respiratory | 0.944 |
| NR-Aromatase | 0.911 |
| Antiviral | Yes |
| Prediction | 0.86066 |